
NYSEHealthcareMedical - Instruments & Supplies
最新数据
US$225.98
+US$5.29 · +2.40%
ResMed Inc. is a leading global medical technology enterprise engaged in the creation, production, distribution, and marketing of healthcare devices and connected digital solutions. The company operates through two primary segments: Sleep and Respiratory Care, and Software as a Service. Its extensive product range addresses a variety of respiratory disorders, encompassing advanced medical and consumer technologies, ventilation devices, diagnostic equipment, mask systems for both clinical and personal use, headgear, and related accessories, alongside dental devices. ResMed also provides sophisticated cloud-based informatics to enhance patient management and operational efficiency. Notable software offerings in its respiratory portfolio include AirView, for remote device monitoring and setting adjustments; myAir, a personalized application designed to support sleep apnea patients with education and troubleshooting for better engagement and adherence; and U-Sleep, a compliance tracking platform for home medical equipment providers. Complementing these are connectivity modules and Propeller solutions. Furthermore, ResMed offers a robust suite of out-of-hospital software. This includes Brightree, a business management platform for various home care service providers (e.g., HME, pharmacy, infusion, orthotics, prosthetics); MatrixCare, providing care management for senior living, skilled nursing, and hospice organizations; and HEALTHCAREfirst, which supplies electronic health records, billing, coding services, and analytics for home health and hospice agencies. ResMed distributes its offerings primarily to sleep clinics, home healthcare dealers, and hospitals via a global network of distributors and a direct sales force, serving approximately 140 countries. Founded in 1989, the company's headquarters are located in San Diego, California.
前收盘价
US$225.98
+US$5.29 · +2.40%
盘前
US$226.25
+US$0.27 · +0.12%
10月8日 4:03 ET
盘中时间采用ET。市场数据可能有所延迟。
ResMed Inc. is a leading global medical technology enterprise engaged in the creation, production, distribution, and marketing of healthcare devices and connected digital solutions. The company operates through two primary segments: Sleep and Respiratory Care, and Software as a Service. Its extensive product range addresses a variety of respiratory disorders, encompassing advanced medical and consumer technologies, ventilation devices, diagnostic equipment, mask systems for both clinical and personal use, headgear, and related accessories, alongside dental devices. ResMed also provides sophisticated cloud-based informatics to enhance patient management and operational efficiency. Notable software offerings in its respiratory portfolio include AirView, for remote device monitoring and setting adjustments; myAir, a personalized application designed to support sleep apnea patients with education and troubleshooting for better engagement and adherence; and U-Sleep, a compliance tracking platform for home medical equipment providers. Complementing these are connectivity modules and Propeller solutions. Furthermore, ResMed offers a robust suite of out-of-hospital software. This includes Brightree, a business management platform for various home care service providers (e.g., HME, pharmacy, infusion, orthotics, prosthetics); MatrixCare, providing care management for senior living, skilled nursing, and hospice organizations; and HEALTHCAREfirst, which supplies electronic health records, billing, coding services, and analytics for home health and hospice agencies. ResMed distributes its offerings primarily to sleep clinics, home healthcare dealers, and hospitals via a global network of distributors and a direct sales force, serving approximately 140 countries. Founded in 1989, the company's headquarters are located in San Diego, California.
日内区间
当前US$225.98
52周区间
当前US$225.98
盘中时间采用ET。市场数据可能有所延迟。
GoAI 评分
买入
估值
99
深度低估
情绪
72
看涨
风险
43
风险偏高
动量
40
动能减弱
完整 GoAI 研究
继续查看更深入的依据、催化因素和风险。
ResMed Inc. is a leading global medical technology enterprise engaged in the creation, production, distribution, and marketing of healthcare devices and connected digital solutions. The company operates through two primary segments: Sleep and Respiratory Care, and Software as a Service. Its extensive product range addresses a variety of respiratory disorders, encompassing advanced medical and consumer technologies, ventilation devices, diagnostic equipment, mask systems for both clinical and personal use, headgear, and related accessories, alongside dental devices. ResMed also provides sophisticated cloud-based informatics to enhance patient management and operational efficiency. Notable software offerings in its respiratory portfolio include AirView, for remote device monitoring and setting adjustments; myAir, a personalized application designed to support sleep apnea patients with education and troubleshooting for better engagement and adherence; and U-Sleep, a compliance tracking platform for home medical equipment providers. Complementing these are connectivity modules and Propeller solutions. Furthermore, ResMed offers a robust suite of out-of-hospital software. This includes Brightree, a business management platform for various home care service providers (e.g., HME, pharmacy, infusion, orthotics, prosthetics); MatrixCare, providing care management for senior living, skilled nursing, and hospice organizations; and HEALTHCAREfirst, which supplies electronic health records, billing, coding services, and analytics for home health and hospice agencies. ResMed distributes its offerings primarily to sleep clinics, home healthcare dealers, and hospitals via a global network of distributors and a direct sales force, serving approximately 140 countries. Founded in 1989, the company's headquarters are located in San Diego, California.
日内区间
当前US$225.98
52周区间
当前US$225.98
盈利能力占已公布营收的百分比。
营收
营业利润
净利润
| 项目(USD) | 2026财年 | 2025财年 | 2024财年 | 2023财年 | 2022财年 |
|---|---|---|---|---|---|
| 营收 | 56.53亿 USD | 51.46亿 USD | 46.85亿 USD | 42.23亿 USD | 35.78亿 USD |
| 销货成本 | 22.02亿 USD | 20.91亿 USD | 20.3亿 USD | 18.67亿 USD | 15.54亿 USD |
| 毛利 | 34.52亿 USD | 30.55亿 USD | 26.55亿 USD | 23.56亿 USD | 20.24亿 USD |
| 研究与开发 | 3.78亿 USD | 3.31亿 USD | 3.08亿 USD | 2.88亿 USD | 2.54亿 USD |
| 销售、一般及管理费用 | 11.2亿 USD | 9.91亿 USD | 9.17亿 USD | 8.74亿 USD | 7.39亿 USD |
| 营业费用 | 15.43亿 USD | 13.7亿 USD | 13.35亿 USD | 12.24亿 USD | 10.24亿 USD |
| 利息支出 | — | 1260.9万 USD | 4570.8万 USD | 4737.9万 USD | 2231.2万 USD |
| 折旧和摊销 | 2.44亿 USD | 2.36亿 USD | 2.16亿 USD | 1.98亿 USD | 1.94亿 USD |
| 营业利润 | 19.08亿 USD | 16.85亿 USD | 13.2亿 USD | 11.32亿 USD | 10亿 USD |
| 净利润 | 15.23亿 USD | 14.01亿 USD | 10.21亿 USD | 8.98亿 USD | 7.79亿 USD |
公司数据更新于 2026年10月8日。
近期已公布业绩
近期已公布业绩
第三方分析师预期可能变化,并非 GoAI 建议。
平均目标
US$242.7
上涨空间 7.40%年度分割调整后的每股现金分配。
US$2.26
2025年(完整年度)+39.5% 自从 2021
2026年(部分年度):US$1.86
US$1.62
2,021
US$1.72
2,022
US$1.84
2,023
US$2.02
2,024
US$2.26
2,025
US$1.86
2,026*
* 在现有股息历史记录中,该日历年仅包含部分期间。
| 行动 | 除息日 | 详情 | 记录日期 | 付款日期 |
|---|---|---|---|---|
股息 | 2026年8月20日 | US$0.66Quarterly | 2026年8月20日 | 2026年9月24日 |
股息 | 2026年5月14日 | US$0.60Quarterly | 2026年5月14日 | 2026年6月18日 |
股息 | 2026年2月12日 | US$0.60Quarterly | 2026年2月12日 | 2026年3月19日 |
股息 | 2025年11月13日 | US$0.60Quarterly | 2025年11月13日 | 2025年12月18日 |
股息 | 2025年8月14日 | US$0.60Quarterly | 2025年8月14日 | 2025年9月18日 |
股息 | 2025年5月8日 | US$0.53Quarterly | 2025年5月8日 | 2025年6月12日 |
除息 2026年8月20日
US$0.66
Quarterly
2026年8月20日登记 · 支付日 2026年9月24日
除息 2026年5月14日
US$0.60
Quarterly
2026年5月14日登记 · 支付日 2026年6月18日
除息 2026年2月12日
US$0.60
Quarterly
2026年2月12日登记 · 支付日 2026年3月19日
除息 2025年11月13日
US$0.60
Quarterly
2025年11月13日登记 · 支付日 2025年12月18日
除息 2025年8月14日
US$0.60
Quarterly
2025年8月14日登记 · 支付日 2025年9月18日
除息 2025年5月8日
US$0.53
Quarterly
2025年5月8日登记 · 支付日 2025年6月12日
报告持有此股票敞口的交易所交易基金。
State Street SPDR S&P 500 ETF1557.T612.07亿0.05%129.41万亿 JPY0.09%JP¥122,700-0.57%
Vanguard Morningstar Total Stock Market ETFVTI11.07亿0.05%2.3万亿 USD0.03%US$381.03-0.40%
Vanguard S&P 500 ETFVOO9.25亿0.05%1.8万亿 USD0.03%US$714.34-0.26%
Vanguard Morningstar Mid-Cap ETFVO7.53亿0.33%2264亿 USD0.03%US$80.14-1.04%
Vanguard Morningstar Growth ETFVUG4.44亿0.12%3846亿 USD0.03%US$92.42-0.24%
iShares Core S&P 500 ETFIVV4.24亿0.05%8996.25亿 USD0.03%US$780.58-0.25%
State Street SPDR S&P 500 ETFSPY3.87亿0.05%8190.39亿 USD0.09%US$777.22-0.24%
First Trust Rising Dividend Achievers ETFRDVY3.63亿1.43%253.67亿 USD0.47%US$78.87-0.74%
State Street SPDR S&P 500 ETF1557.T
Vanguard Morningstar Total Stock Market ETFVTI
Vanguard S&P 500 ETFVOO
Vanguard Morningstar Mid-Cap ETFVO
Vanguard Morningstar Growth ETFVUG
iShares Core S&P 500 ETFIVV
State Street SPDR S&P 500 ETFSPY
First Trust Rising Dividend Achievers ETFRDVYAI 生成内容及延迟市场数据仅供信息与教育用途,不构成投资建议。